anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Resolution

Beat collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 42,534
Current window 29,311-29,340
Pages 1,418
Rows per page 30
Beat: Resolutionclear collectionreset all
18 30 60

Beat

29,311-29,340 of 42,534

filter-aware
15
AstraZeneca | ESG Presentation Deck | 16 slidesAstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future State1 hit
16
AstraZeneca | ESG Presentation Deck | 16 slidesAstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future State1 hit
11
The slide uses a combination of stacked bar charts and line charts to illustrate operational and financial trends.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
12
The slide uses a dual-chart layout to contrast operational KPIs (DAU, ARPDAU) with financial KPIs (Net Revenue, Adj EBITDA).Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
13
The slide uses a three-column layout to categorize operational efficiency initiatives.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · Action1 hit
14
Azerion | Results Presentation Deck | 15 slidesAzerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · Action1 hit
15
Azerion | Results Presentation Deck | 15 slidesAzerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · Action1 hit
10
Bionomics | Results Presentation Deck | 27 slidesBionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
11
The slide uses a numbered list format to structure the research objectives.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
12
The slide outlines a clinical trial protocol using a process flow diagram.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
13
The slide uses a process flow diagram to map clinical assessment timing against specific study phases.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
14
The slide uses a dual-chart layout to contrast 'Average' vs 'AUC' metrics, highlighting the shift from primary to post-hoc analysis.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
15
Clinical trial data presentation showing population counts and demographic averages.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
16
The slide uses a line chart to demonstrate pharmacological activity in a Social Anxiety Disorder (SAD) trial.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
17
The slide compares a historical benchmark (Diazepam) with the company's drug (BNC210) to establish clinical relevance.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
18
The slide uses a combination of a line chart illustrating the task phases and forest plots to show confidence intervals and p-values for various metrics.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
19
The slide uses a combination of a line chart showing AUC calculation and a forest plot showing differences from placebo across different dose groups.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
20
The slide highlights specific p-values (0.063, 0.069, 0.022, 0.023) in green boxes to emphasize statistical significance.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
21
The slide uses a forest plot to visualize confidence intervals and p-values for different dosage groups (225mg, 675mg, Overall) across two population segments (FAS and Age <=30).Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
22
Bionomics | Results Presentation Deck | 27 slidesBionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Solution1 hit
23
Bionomics | Results Presentation Deck | 27 slidesBionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
24
The table categorizes adverse events by relationship to study drug, severity, and system organ class.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
25
The slide uses a numbered list format to present study outcomes across seven clinical domains.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
26
Bionomics | Results Presentation Deck | 27 slidesBionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
27
Bionomics | Results Presentation Deck | 27 slidesBionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
17
Includes footnotes explaining the non-GAAP nature of the measures and the change in definition for 2023.Cano Health | Results Presentation Deck | 21 slides · Cano Health
Deck Investor relations Beat · Action1 hit
18
Includes a secondary reconciliation for a modified definition of Adjusted EBITDA.Cano Health | Results Presentation Deck | 21 slides · Cano Health
Deck Investor relations Beat · Action1 hit
19
Includes specific financial impact of the definition change for 2020-2022.Cano Health | Results Presentation Deck | 21 slides · Cano Health
Deck Investor relations Beat · Action1 hit
20
The chart highlights a significant spike in COVID-19 admissions in Jan 2022 (21.1) compared to a much lower rate in Nov 2022 (0.3).Cano Health | Results Presentation Deck | 21 slides · Cano Health
Deck Investor relations Beat · Action1 hit
21
Cano Health | Results Presentation Deck | 21 slidesCano Health | Results Presentation Deck | 21 slides · Cano Health
Deck Investor relations Beat · Action1 hit